Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome.
about
The HELLP syndrome: clinical issues and management. A ReviewThe HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 womenClinical and biophysical aspects of HELLP-syndrome.HELLP syndrome.The HELLP syndrome, a prospective study.Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy.Immune thrombocytopenia in pregnancyMilestones in the quest for best management of patients with HELLP syndrome (microangiopathic hemolytic anemia, hepatic dysfunction, thrombocytopenia).Coagulation/fibrinolysis and laboratory characteristics of pregnant women with severely depressed antithrombin activity.Clinical-Pathological Conference Series from the Medical University of Graz Case No 155: 26-year-old woman in third trimester of pregnancy with epigastric pain and thrombocytopenia.Anesthetic considerations in HELLP syndrome.Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome.Haemolytic anaemia after nitrofurantoin treatment in a pregnant woman with G6PD deficiencyAccuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review.DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia.Laboratory abnormalities in pregnancy-associated hypertension: frequency and association with pregnancy outcomesProspective study of liver dysfunction in pregnancy in Southwest WalesHelicobacter pylori's virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation.[HELLP syndrome: report of 61 cases and literature review]Placental DNA methylation at term reflects maternal serum levels of INHA and FN1, but not PAPPA, early in pregnancySevere Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at <34 and ≥34 Weeks' Gestation.CHOROIDAL MORPHOLOGY IN A PATIENT WITH HELLP SYNDROME.Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome.Hellp syndrome and composite major maternal morbidity: importance of Mississippi classification system.A clinicohistopathologic comparison between HELLP syndrome and severe preeclampsia.Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro.Factors contributing to adverse maternal outcomes in patients with HELLP syndrome.Innate Immune System at the Maternal-Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes.Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know?The development of partnership after hypertensive diseases in pregnancy.Mechanistic Insight into Long Noncoding RNAs and the Placenta.Hemolysis, elevated liver enzymes, and low platelet syndrome: Outcomes for patients admitted to intensive care at a tertiary referral hospital.HELLP syndrome: 8 years of experience from a tertiary referral center in western Turkey.Expression of inflammatory cytokines in placentas from pregnancies complicated with preeclampsia and HELLP syndrome.Critically ill obstetric patients with partial HELLP syndrome: still need HELP?HELLP syndrome: utility of specific classifications as prognostic tools.First trimester prediction of HELLP syndrome.Partial HELLP syndrome: maternal, perinatal, subsequent pregnancy and long-term maternal outcomes.An analysis of HELLP syndrome cases: does platelet count predict adverse maternal and fetal outcomes in women with HELLP syndrome?The role of plasma exchange in HELLP syndrome.
P2860
Q21261342-17532FB1-DD01-4061-B52E-D212542B4416Q28213032-85853033-3F06-4275-911B-C08E19AB2CBBQ31125913-1938015F-4C39-403C-B7CB-8982234B25D5Q33334624-A26E06BA-437F-4036-9230-BFC92CA68994Q33339983-6949715F-082F-4DEB-A6F0-6E5019850EB6Q33340971-6463B236-DBB4-4E63-9183-82B7463014F4Q33387170-0BF1612E-FB7A-4FAA-8B54-3A2A0D7213F2Q33406627-BADA453F-2387-4331-948B-78B119A24C6CQ33408485-3DB5F053-6C0C-48BB-B7F8-5A9FB6C1FDFCQ33424960-770E1C40-E70A-4AAD-97F3-D1ED9938B296Q33426530-FF43528D-EBEF-46BD-91B6-ABF846D1D9CBQ33430320-0093F493-3910-447E-B9E7-E576F45DA66DQ33628578-A0768C03-B35A-49BA-B2BB-60CD885BF43BQ33830864-E8FE2417-F1A5-4456-9655-E57F7839DF32Q34329498-DE940E23-C935-453F-A6B5-ABCBBEBE30E9Q34609592-6DC67B72-1BBF-4DC8-A0E5-A63AD67CF035Q35595174-26C0A9A9-4AB4-481B-8DA7-BE5EF5D98F7CQ35627269-238F1F79-2581-45DF-8AF9-D446DC0A90B4Q35885406-742082CA-CDBD-4836-BB06-040506761152Q36366144-4068DAB9-C86D-4E4D-9DFA-A10A303B2B90Q36407648-6E47C8B6-4E38-43DC-A2EF-5BDC1CF73D0EQ36930401-5D7DAB58-03D8-4B79-8477-42F4E06110C6Q37611090-229B92EB-6C39-4F08-B077-B2FAD4DF3B3AQ38079635-08DA3F86-CA9C-41E3-B853-7AAFF39C4FF1Q38444723-CD285147-5840-4A9F-9C6B-DA8CF55983C0Q38520978-87481363-5CA3-452A-99F5-9C8521B100AEQ38636657-3872378D-3F37-4663-87CE-1F03A0DDA415Q38816011-2274B375-9D85-4D86-836F-C43D815CBCB7Q38834904-2AE0BF6A-FE4F-40D3-92C6-AA26CABD2779Q39187887-AF392D07-EF2F-4F2A-B351-57487FAFC392Q39400476-223A319F-8C11-462E-872D-3D2B9CF000D6Q40593286-7C85BDA8-7221-4AAF-871D-9784D4A60D6EQ44628201-3FF021DA-3312-4E3D-9CBF-C76DC103DC5AQ45345332-4228E487-73CF-42C0-8998-B9DE0CAABB0DQ45791879-F53F3CC7-2F75-4772-805F-7265A4E80075Q45809278-85D2E424-6F65-41E1-A10B-AC0023C48808Q46169022-B6785B55-6777-4A85-A063-479A1CF0B842Q46317231-FD556727-6248-4178-8E7A-C4A55944DE66Q46331247-407059D5-8344-42CB-9F15-2B8CA1249288Q46344580-96D6ECE3-DE99-41EC-B611-BD11E584F49F
P2860
Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome.
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Clinical utility of strict dia ...... , and low platelets) syndrome.
@ast
Clinical utility of strict dia ...... , and low platelets) syndrome.
@en
Clinical utility of strict dia ...... , and low platelets) syndrome.
@nl
type
label
Clinical utility of strict dia ...... , and low platelets) syndrome.
@ast
Clinical utility of strict dia ...... , and low platelets) syndrome.
@en
Clinical utility of strict dia ...... , and low platelets) syndrome.
@nl
prefLabel
Clinical utility of strict dia ...... , and low platelets) syndrome.
@ast
Clinical utility of strict dia ...... , and low platelets) syndrome.
@en
Clinical utility of strict dia ...... , and low platelets) syndrome.
@nl
P2093
P1476
Clinical utility of strict dia ...... s, and low platelets) syndrome
@en
P2093
A Y Frangieh
S A Friedman
P304
P356
10.1016/S0002-9378(96)70162-X
P407
P577
1996-08-01T00:00:00Z